BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24105979)

  • 1. Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement.
    Paino F; La Noce M; Tirino V; Naddeo P; Desiderio V; Pirozzi G; De Rosa A; Laino L; Altucci L; Papaccio G
    Stem Cells; 2014 Jan; 32(1):279-89. PubMed ID: 24105979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic Interactions between the Glucocorticoid Receptor and HDAC2 Regulate Osteocalcin Expression in VPA-Treated MSCs.
    La Noce M; Mele L; Laino L; Iolascon G; Pieretti G; Papaccio G; Desiderio V; Tirino V; Paino F
    Cells; 2019 Mar; 8(3):. PubMed ID: 30841579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
    Duncan HF; Smith AJ; Fleming GJ; Cooper PR
    J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
    Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
    J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Selective Histone Deacetylase Inhibitor MI192 Enhances the Osteogenic Differentiation Efficacy of Human Dental Pulp Stromal Cells.
    Man K; Lawlor L; Jiang LH; Yang XB
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
    Foti SB; Chou A; Moll AD; Roskams AJ
    Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
    Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
    Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells.
    Duncan HF; Smith AJ; Fleming GJ; Cooper PR
    Exp Cell Res; 2013 Jun; 319(10):1534-43. PubMed ID: 23562654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant control of adipogenesis by histone deacetylases 1 and 2.
    Haberland M; Carrer M; Mokalled MH; Montgomery RL; Olson EN
    J Biol Chem; 2010 May; 285(19):14663-70. PubMed ID: 20190228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
    Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
    J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
    Jeong SG; Ohn T; Kim SH; Cho GW
    Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
    Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
    J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells.
    Lee S; Park JR; Seo MS; Roh KH; Park SB; Hwang JW; Sun B; Seo K; Lee YS; Kang SK; Jung JW; Kang KS
    Cell Prolif; 2009 Dec; 42(6):711-20. PubMed ID: 19689470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells.
    Yu Y; Oh SY; Kim HY; Choi JY; Jo SA; Jo I
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valproic acid on the hepatic differentiation of mesenchymal stem cells in 2D and 3D microenvironments.
    Rashid S; Qazi RE; Malick TS; Salim A; Khan I; Ilyas A; Haneef K
    Mol Cell Biochem; 2021 Feb; 476(2):909-919. PubMed ID: 33111212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases.
    Lund RJ; Emani MR; Barbaric I; Kivinen V; Jones M; Baker D; Gokhale P; Nykter M; Lahesmaa R; Andrews PW
    Stem Cell Res; 2013 Nov; 11(3):1022-36. PubMed ID: 23941963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3.
    Leng Y; Wang J; Wang Z; Liao HM; Wei M; Leeds P; Chuang DM
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.